Together with increased CATi, dyslipidemia and increased CRP were also associated to unfavorable outcome in diabetic patients suggesting a conundrum of metabolic and inflammatory pathways playing a central role in the severity of COVID-19 in diabetic patients. Here, CRP is linked to metabolic syndrome.